Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte precursor cell | 9 studies | 28% ± 13% | |
endothelial cell of lymphatic vessel | 8 studies | 25% ± 10% | |
glutamatergic neuron | 8 studies | 46% ± 25% | |
retinal rod cell | 7 studies | 25% ± 7% | |
GABAergic neuron | 7 studies | 45% ± 24% | |
endothelial cell | 5 studies | 28% ± 7% | |
cardiac muscle cell | 5 studies | 58% ± 10% | |
astrocyte | 5 studies | 24% ± 9% | |
neuron | 4 studies | 36% ± 17% | |
epithelial cell | 4 studies | 27% ± 7% | |
interneuron | 4 studies | 52% ± 24% | |
GABAergic interneuron | 3 studies | 28% ± 3% | |
retinal ganglion cell | 3 studies | 24% ± 2% | |
granule cell | 3 studies | 22% ± 8% | |
kidney distal convoluted tubule epithelial cell | 3 studies | 21% ± 4% | |
kidney loop of Henle epithelial cell | 3 studies | 22% ± 4% | |
renal alpha-intercalated cell | 3 studies | 34% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 100% | 2246.11 | 89 / 89 | 98% | 19.20 | 886 / 901 |
prostate | 98% | 1084.20 | 241 / 245 | 97% | 8.85 | 486 / 502 |
thymus | 98% | 1053.01 | 643 / 653 | 86% | 4.43 | 522 / 605 |
brain | 88% | 958.70 | 2313 / 2642 | 88% | 4.08 | 621 / 705 |
ovary | 84% | 539.05 | 152 / 180 | 67% | 3.30 | 288 / 430 |
uterus | 96% | 907.15 | 163 / 170 | 51% | 3.46 | 234 / 459 |
lung | 75% | 616.47 | 434 / 578 | 63% | 3.95 | 728 / 1155 |
esophagus | 93% | 2057.01 | 1350 / 1445 | 44% | 2.99 | 80 / 183 |
breast | 64% | 494.51 | 296 / 459 | 68% | 7.17 | 764 / 1118 |
pancreas | 72% | 407.41 | 235 / 328 | 60% | 2.83 | 107 / 178 |
stomach | 87% | 880.58 | 312 / 359 | 25% | 1.72 | 72 / 286 |
bladder | 86% | 820.62 | 18 / 21 | 20% | 1.09 | 102 / 504 |
muscle | 100% | 8381.98 | 803 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1571.62 | 1328 / 1335 | 0% | 0 | 0 / 0 |
intestine | 79% | 1522.80 | 767 / 966 | 18% | 0.97 | 97 / 527 |
heart | 97% | 5488.45 | 837 / 861 | 0% | 0 | 0 / 0 |
liver | 6% | 29.66 | 14 / 226 | 60% | 4.55 | 242 / 406 |
adipose | 64% | 505.42 | 773 / 1204 | 0% | 0 | 0 / 0 |
spleen | 61% | 348.21 | 148 / 241 | 0% | 0 | 0 / 0 |
adrenal gland | 32% | 155.55 | 82 / 258 | 23% | 0.81 | 53 / 230 |
skin | 35% | 189.67 | 625 / 1809 | 11% | 0.51 | 54 / 472 |
tonsil | 0% | 0 | 0 / 0 | 36% | 1.97 | 16 / 45 |
eye | 0% | 0 | 0 / 0 | 5% | 0.20 | 4 / 80 |
peripheral blood | 0% | 1.02 | 2 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0097009 | Biological process | energy homeostasis |
GO_0071380 | Biological process | cellular response to prostaglandin E stimulus |
GO_0042149 | Biological process | cellular response to glucose starvation |
GO_0071333 | Biological process | cellular response to glucose stimulus |
GO_1904428 | Biological process | negative regulation of tubulin deacetylation |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_1905691 | Biological process | lipid droplet disassembly |
GO_0055089 | Biological process | fatty acid homeostasis |
GO_0010629 | Biological process | negative regulation of gene expression |
GO_0007165 | Biological process | signal transduction |
GO_0032007 | Biological process | negative regulation of TOR signaling |
GO_0008610 | Biological process | lipid biosynthetic process |
GO_0006338 | Biological process | chromatin remodeling |
GO_1903944 | Biological process | negative regulation of hepatocyte apoptotic process |
GO_0042752 | Biological process | regulation of circadian rhythm |
GO_0014850 | Biological process | response to muscle activity |
GO_0062028 | Biological process | regulation of stress granule assembly |
GO_0071277 | Biological process | cellular response to calcium ion |
GO_2000758 | Biological process | positive regulation of peptidyl-lysine acetylation |
GO_0031669 | Biological process | cellular response to nutrient levels |
GO_0006633 | Biological process | fatty acid biosynthetic process |
GO_0034599 | Biological process | cellular response to oxidative stress |
GO_0043066 | Biological process | negative regulation of apoptotic process |
GO_0016239 | Biological process | positive regulation of macroautophagy |
GO_0010508 | Biological process | positive regulation of autophagy |
GO_1990044 | Biological process | protein localization to lipid droplet |
GO_0006914 | Biological process | autophagy |
GO_0070507 | Biological process | regulation of microtubule cytoskeleton organization |
GO_1903829 | Biological process | positive regulation of protein localization |
GO_0016055 | Biological process | Wnt signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0016241 | Biological process | regulation of macroautophagy |
GO_0006695 | Biological process | cholesterol biosynthetic process |
GO_0045821 | Biological process | positive regulation of glycolytic process |
GO_0048511 | Biological process | rhythmic process |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0042593 | Biological process | glucose homeostasis |
GO_0016607 | Cellular component | nuclear speck |
GO_0031588 | Cellular component | nucleotide-activated protein kinase complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0043025 | Cellular component | neuronal cell body |
GO_0030425 | Cellular component | dendrite |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0030424 | Cellular component | axon |
GO_0010494 | Cellular component | cytoplasmic stress granule |
GO_0005634 | Cellular component | nucleus |
GO_0004712 | Molecular function | protein serine/threonine/tyrosine kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0003682 | Molecular function | chromatin binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0047322 | Molecular function | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity |
GO_0004672 | Molecular function | protein kinase activity |
GO_0140823 | Molecular function | histone H2BS36 kinase activity |
GO_0004679 | Molecular function | AMP-activated protein kinase activity |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PRKAA2 |
Protein name | [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase (EC 2.7.11.31) (Acetyl-CoA carboxylase kinase) (Hydroxymethylglutaryl-CoA reductase kinase) AMP-activated protein kinase alpha-2 subunit variant 2 5'-AMP-activated protein kinase catalytic subunit alpha-2 (EC 2.7.11.1) (EC 2.7.11.31) (Acetyl-CoA carboxylase kinase) (Hydroxymethylglutaryl-CoA reductase kinase) 5'-AMP-activated protein kinase catalytic subunit alpha-2 (AMPK subunit alpha-2) (EC 2.7.11.1) (Acetyl-CoA carboxylase kinase) (ACACA kinase) (Hydroxymethylglutaryl-CoA reductase kinase) (HMGCR kinase) (EC 2.7.11.31) |
Synonyms | AMPK2 AMPK |
Description | FUNCTION: Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism . In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation . AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators . Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively . Promotes lipolysis of lipid droplets by mediating phosphorylation of isoform 1 of CHKA (CHKalpha2) . Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3 (By similarity). Involved in insulin receptor/INSR internalization . AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160 (By similarity). Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A . Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm (By similarity). In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription (By similarity). Acts as a key regulator of cell growth and proliferation by phosphorylating FNIP1, TSC2, RPTOR, WDR24 and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2 . Also phosphorylates and inhibits GATOR2 subunit WDR24 in response to nutrient limitation, leading to suppress glucose-mediated mTORC1 activation . In response to energetic stress, phosphorylates FNIP1, inactivating the non-canonical mTORC1 signaling, thereby promoting nuclear translocation of TFEB and TFE3, and inducing transcription of lysosomal or autophagy genes . In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1 . In that process also activates WDR45/WIPI4 . Phosphorylates CASP6, thereby preventing its autoprocessing and subsequent activation . AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it (By similarity). May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it (By similarity). Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin . Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1 . Plays an important role in the differential regulation of pro-autophagy (composed of PIK3C3, BECN1, PIK3R4 and UVRAG or ATG14) and non-autophagy (composed of PIK3C3, BECN1 and PIK3R4) complexes, in response to glucose starvation (By similarity). Can inhibit the non-autophagy complex by phosphorylating PIK3C3 and can activate the pro-autophagy complex by phosphorylating BECN1 (By similarity). Upon glucose starvation, promotes ARF6 activation in a kinase-independent manner leading to cell migration . Upon glucose deprivation mediates the phosphorylation of ACSS2 at 'Ser-659', which exposes the nuclear localization signal of ACSS2, required for its interaction with KPNA1 and nuclear translocation . . |
Accessions | ENST00000371244.9 K9J960 P54646 A0MZF5 K9J973 |